|
Volumn 36, Issue 7, 2004, Pages 2182-2183
|
Efficacy of basiliximab induction therapy in ABO-incompatible kidney transplantation: A rapid steroid withdrawal protocol
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTIBODY;
BASILIXIMAB;
CYCLOSPORIN;
METHYLPREDNISOLONE;
MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER;
STEROID;
ACUTE GRAFT REJECTION;
ADULT;
AGED;
BIOPSY;
BLOOD GROUP ABO INCOMPATIBILITY;
CLINICAL ARTICLE;
CONFERENCE PAPER;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG SCREENING;
DRUG WITHDRAWAL;
FEMALE;
GRAFT SURVIVAL;
HUMAN;
IMMUNOSUPPRESSIVE TREATMENT;
INCIDENCE;
KIDNEY DONOR;
KIDNEY TRANSPLANTATION;
LIVING DONOR;
MAINTENANCE THERAPY;
MALE;
PLASMAPHERESIS;
POSTOPERATIVE PERIOD;
PRIORITY JOURNAL;
RECIPIENT;
SPLENECTOMY;
SURGICAL PATIENT;
SURVIVAL RATE;
TREATMENT OUTCOME;
ABO BLOOD-GROUP SYSTEM;
ADRENAL CORTEX HORMONES;
ADULT;
AGED;
ANTIBODIES, MONOCLONAL;
BIOPSY;
BLOOD GROUP INCOMPATIBILITY;
DRUG ADMINISTRATION SCHEDULE;
FEMALE;
GRAFT REJECTION;
HUMANS;
IMMUNOSUPPRESSIVE AGENTS;
KIDNEY TRANSPLANTATION;
MALE;
MIDDLE AGED;
RECOMBINANT FUSION PROTEINS;
|
EID: 7044220335
PISSN: 00411345
EISSN: None
Source Type: Journal
DOI: 10.1016/j.transproceed.2004.07.051 Document Type: Conference Paper |
Times cited : (10)
|
References (4)
|